Upstream Bio (UPB) Other Operating Expenses (2024 - 2026)

Upstream Bio's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 5.6% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$4.6 million (down 77.37% YoY), while the FY2025 annual figure was -$4.5 million, down 127.77% from the prior year.
• Other Operating Expenses was -$1.1 million for Q1 2026 at Upstream Bio, up from -$1.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of -$334000.0 in Q2 2024 to a low of -$1.3 million in Q4 2025.
• Historically, Other Operating Expenses has averaged -$843666.7 across 3 years, with a median of -$891000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses plunged 273.95% in 2025, then declined 5.6% in 2026.
• A 3-year view of Other Operating Expenses shows it stood at -$836000.0 in 2024, then plunged by 56.58% to -$1.3 million in 2025, then grew by 14.97% to -$1.1 million in 2026.
• The last three Other Operating Expenses figures came in at -$1.1 million (Q1 2026), -$1.3 million (Q4 2025), and -$891000.0 (Q3 2025), per Business Quant data.